Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,733 | 395 | 99.4% |
| Education | $35.95 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $737.88 | 57 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $687.63 | 38 | $0 (2022) |
| Novo Nordisk Inc | $574.67 | 48 | $0 (2022) |
| Amgen Inc. | $561.45 | 38 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $388.09 | 29 | $0 (2022) |
| Lilly USA, LLC | $349.55 | 31 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $348.46 | 21 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $294.93 | 17 | $0 (2022) |
| Amarin Pharma Inc. | $217.21 | 14 | $0 (2021) |
| ABBVIE INC. | $203.04 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $403.94 | 23 | Arbor Pharmaceuticals, Inc. ($49.48) |
| 2021 | $520.61 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($108.86) |
| 2020 | $690.79 | 42 | GlaxoSmithKline, LLC. ($118.80) |
| 2019 | $1,399 | 99 | AstraZeneca Pharmaceuticals LP ($229.47) |
| 2018 | $1,423 | 99 | GlaxoSmithKline, LLC. ($212.76) |
| 2017 | $1,332 | 106 | GlaxoSmithKline, LLC. ($202.41) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 06/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/03/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation | ||||||
| 05/20/2022 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/18/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 05/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Cardio-renal | ||||||
| 05/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Diabetes | ||||||
| 04/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: DIABETES | ||||||
| 04/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2022 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $18.13 | General |
| 04/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: RESPIRATORY | ||||||
| 03/29/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Cardio-renal | ||||||
| 02/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: RESPIRATORY | ||||||
| 02/18/2022 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 02/08/2022 | EISAI INC. | Aduhelm (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Neurology | ||||||
| 02/05/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/15/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 01/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 01/04/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/14/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 11/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 428 | 595 | $55,696 | $15,967 |
| 2021 | 11 | 849 | 1,429 | $125,706 | $55,900 |
| 2020 | 14 | 1,119 | 1,823 | $133,195 | $54,420 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 238 | $39,198 | $11,681 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 44 | $5,826 | $1,836 | 31.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 92 | 92 | $4,784 | $1,214 | 25.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 67 | 71 | $2,840 | $686.51 | 24.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 80 | 136 | $2,040 | $437.51 | 21.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $1,008 | $112.30 | 11.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 511 | $80,227 | $38,520 | 48.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 66 | 68 | $4,556 | $4,299 | 94.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 67 | $7,102 | $3,574 | 50.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 137 | 197 | $10,244 | $2,601 | 25.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 11 | 11 | $3,509 | $2,380 | 67.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 86 | 138 | $5,520 | $1,329 | 24.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 72 | 74 | $3,256 | $1,165 | 35.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 93 | 93 | $6,696 | $987.58 | 14.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 94 | 218 | $3,270 | $709.67 | 21.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $660.00 | $226.30 | 34.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 36 | 37 | $666.00 | $108.70 | 16.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 195 | 485 | $73,696 | $30,764 | 41.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 95 | 126 | $12,954 | $5,408 | 41.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 86 | 86 | $5,762 | $5,000 | 86.8% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 14 | 14 | $4,466 | $2,932 | 65.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 140 | 191 | $9,932 | $2,509 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 100 | 100 | $4,400 | $1,543 | 35.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 14 | 14 | $2,128 | $1,527 | 71.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 97 | 137 | $5,480 | $1,303 | 23.8% |
About Dr. Ghai Lu, MD
Dr. Ghai Lu, MD is a Internal Medicine healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588763429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ghai Lu, MD has received a total of $5,769 in payments from pharmaceutical and medical device companies, with $403.94 received in 2022. These payments were reported across 400 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,733).
As a Medicare-enrolled provider, Lu has provided services to 2,396 Medicare beneficiaries, totaling 3,847 services with total Medicare billing of $126,287. Data is available for 3 years (2020–2022), covering 31 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bedford, OH
- Active Since 09/21/2006
- Last Updated 12/31/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588763429
Products in Payments
- FARXIGA (Drug) $396.62
- XARELTO (Drug) $317.47
- TRELEGY ELLIPTA (Drug) $275.68
- Aimovig (Biological) $253.54
- Vascepa (Drug) $217.21
- TRULICITY (Drug) $211.62
- Ozempic (Drug) $193.40
- BREO (Drug) $183.40
- ANORO (Drug) $177.35
- Prolia (Biological) $173.69
- TOUJEO (Drug) $169.64
- TRADJENTA (Drug) $165.52
- SYMBICORT (Drug) $156.99
- LONHALA MAGNAIR (Drug) $152.84
- LINZESS (Drug) $149.51
- Victoza (Drug) $146.58
- Edarbyclor (Drug) $140.80
- TUDORZA PRESSAIR (Drug) $104.34
- SPIRIVA RESPIMAT (Drug) $100.06
- JANUVIA (Drug) $91.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bedford
Dr. Michael Delaughter, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $1.7M
Scott Greenberg, Md, MD
Internal Medicine — Payments: $171,246
Dr. Venkatesan Vidi, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $17,343
Dr. Elmer Smith, Md, MD
Internal Medicine — Payments: $17,311
Paul Kim, Md, MD
Internal Medicine — Payments: $15,775
Alisa Thamwiwat, M.d, M.D
Internal Medicine — Payments: $13,867